155 related articles for article (PubMed ID: 17638883)
1. BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines.
Naderi A; Teschendorff AE; Beigel J; Cariati M; Ellis IO; Brenton JD; Caldas C
Cancer Res; 2007 Jul; 67(14):6725-36. PubMed ID: 17638883
[TBL] [Abstract][Full Text] [Related]
2. Brain-Expressed X-linked (BEX) proteins in human cancers.
Kazi JU; Kabir NN; Rönnstrand L
Biochim Biophys Acta; 2015 Dec; 1856(2):226-33. PubMed ID: 26408910
[TBL] [Abstract][Full Text] [Related]
3. BEX2 regulates mitochondrial apoptosis and G1 cell cycle in breast cancer.
Naderi A; Liu J; Bennett IC
Int J Cancer; 2010 Apr; 126(7):1596-610. PubMed ID: 19711341
[TBL] [Abstract][Full Text] [Related]
4. A20/TNFAIP3, a new estrogen-regulated gene that confers tamoxifen resistance in breast cancer cells.
Vendrell JA; Ghayad S; Ben-Larbi S; Dumontet C; Mechti N; Cohen PA
Oncogene; 2007 Jul; 26(32):4656-67. PubMed ID: 17297453
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the Bex gene family in humans, mice, and rats.
Alvarez E; Zhou W; Witta SE; Freed CR
Gene; 2005 Aug; 357(1):18-28. PubMed ID: 15958283
[TBL] [Abstract][Full Text] [Related]
6. Molecular functions of brain expressed X-linked 2 (BEX2) in malignancies.
Naderi A
Exp Cell Res; 2019 Mar; 376(2):221-226. PubMed ID: 30779920
[TBL] [Abstract][Full Text] [Related]
7. Nerve growth factor/nuclear factor-kappaB pathway as a therapeutic target in breast cancer.
Naderi A; Hughes-Davies L
J Cancer Res Clin Oncol; 2009 Feb; 135(2):211-6. PubMed ID: 18716795
[TBL] [Abstract][Full Text] [Related]
8. Induction of methionine adenosyltransferase 2A in tamoxifen-resistant breast cancer cells.
Phuong NT; Kim SK; Im JH; Yang JW; Choi MC; Lim SC; Lee KY; Kim YM; Yoon JH; Kang KW
Oncotarget; 2016 Mar; 7(12):13902-16. PubMed ID: 26418898
[TBL] [Abstract][Full Text] [Related]
9. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
[TBL] [Abstract][Full Text] [Related]
10. A feedback loop between BEX2 and ErbB2 mediated by c-Jun signaling in breast cancer.
Naderi A; Liu J; Francis GD
Int J Cancer; 2012 Jan; 130(1):71-82. PubMed ID: 21384344
[TBL] [Abstract][Full Text] [Related]
11. The relationships between snail1 and estrogen receptor signaling in breast cancer cells.
Scherbakov AM; Andreeva OE; Shatskaya VA; Krasil'nikov MA
J Cell Biochem; 2012 Jun; 113(6):2147-55. PubMed ID: 22307688
[TBL] [Abstract][Full Text] [Related]
12. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.
Hui AM; Zhang W; Chen W; Xi D; Purow B; Friedman GC; Fine HA
Cancer Res; 2004 Dec; 64(24):9115-23. PubMed ID: 15604281
[TBL] [Abstract][Full Text] [Related]
13. Bex1, a novel interactor of the p75 neurotrophin receptor, links neurotrophin signaling to the cell cycle.
Vilar M; Murillo-Carretero M; Mira H; Magnusson K; Besset V; Ibáñez CF
EMBO J; 2006 Mar; 25(6):1219-30. PubMed ID: 16498402
[TBL] [Abstract][Full Text] [Related]
14. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor-ĸB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells.
Oida K; Matsuda A; Jung K; Xia Y; Jang H; Amagai Y; Ahn G; Nishikawa S; Ishizaka S; Jensen-Jarolim E; Matsuda H; Tanaka A
Sci Rep; 2014 Feb; 4():4057. PubMed ID: 24531845
[TBL] [Abstract][Full Text] [Related]
16. OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells.
Bhatt S; Stender JD; Joshi S; Wu G; Katzenellenbogen BS
Oncogene; 2016 Nov; 35(44):5722-5734. PubMed ID: 27065334
[TBL] [Abstract][Full Text] [Related]
17. Effect of ulinastatin on growth inhibition, apoptosis of breast carcinoma cells is related to a decrease in signal conduction of JNk-2 and NF-κB.
Wang H; Sun X; Gao F; Zhong B; Zhang YH; Sun Z
J Exp Clin Cancer Res; 2012 Jan; 31(1):2. PubMed ID: 22217202
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.
Patel NM; Nozaki S; Shortle NH; Bhat-Nakshatri P; Newton TR; Rice S; Gelfanov V; Boswell SH; Goulet RJ; Sledge GW; Nakshatri H
Oncogene; 2000 Aug; 19(36):4159-69. PubMed ID: 10962577
[TBL] [Abstract][Full Text] [Related]
19. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
20. The NF-κB Pathway Promotes Tamoxifen Tolerance and Disease Recurrence in Estrogen Receptor-Positive Breast Cancers.
Kastrati I; Joosten SEP; Semina SE; Alejo LH; Brovkovych SD; Stender JD; Horlings HM; Kok M; Alarid ET; Greene GL; Linn SC; Zwart W; Frasor J
Mol Cancer Res; 2020 Jul; 18(7):1018-1027. PubMed ID: 32245803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
